BRPI0817781A2 - piperazino-diidroteinopirimidinas substituídas com heterociclo - Google Patents

piperazino-diidroteinopirimidinas substituídas com heterociclo

Info

Publication number: BRPI0817781A2
Authority: BR; Brazil
Prior art keywords: dihydroteinopyrimidines; heterocycle substituted; substituted piperazine; piperazine; heterocycle
Prior art date: 2007-10-19

Application number

BRPI0817781A

Other languages

English (en)

Inventor

Hoenke Christoph

Fiegen Dennis

Martyres Domnic

Dollinger Horst

Klinder Klaus

Pouzet Pascale

Nickolaus Peter

Anderskewitz Ralf

Goeggel Rolf

Fox Thomas

Original Assignee

Boehringer Ingelheim Int

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2007-10-19

Filing date

2008-10-16

Publication date

2019-09-24

2008-10-16 Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int

2019-09-24 Publication of BRPI0817781A2 publication Critical patent/BRPI0817781A2/pt

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/10—Expectorants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Pulmonology (AREA)
Hematology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Psychiatry (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Immunology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Heart & Thoracic Surgery (AREA)
Orthopedic Medicine & Surgery (AREA)
Otolaryngology (AREA)
Psychology (AREA)
Ophthalmology & Optometry (AREA)
Oncology (AREA)
Physical Education & Sports Medicine (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Gastroenterology & Hepatology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

BRPI0817781A 2007-10-19 2008-10-16 piperazino-diidroteinopirimidinas substituídas com heterociclo BRPI0817781A2 (pt)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
EP07118911		2007-10-19
PCT/EP2008/063983 WO2009050242A2 (de)	2007-10-19	2008-10-16	Heterocyclus-substituierte piperazino-dihydrothienopyrimidine

Publications (1)

Publication Number	Publication Date
BRPI0817781A2 true BRPI0817781A2 (pt)	2019-09-24

Family

ID=39204738

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BRPI0817781A BRPI0817781A2 (pt)	2007-10-19	2008-10-16	piperazino-diidroteinopirimidinas substituídas com heterociclo

Country Status (18)

Country	Link
US (2)	US8637519B2 (pt)
EP (1)	EP2205609B1 (pt)
JP (1)	JP5341899B2 (pt)
KR (1)	KR20100075930A (pt)
CN (1)	CN101827853A (pt)
AR (1)	AR069076A1 (pt)
AU (1)	AU2008313742B2 (pt)
BR (1)	BRPI0817781A2 (pt)
CA (1)	CA2702524A1 (pt)
CL (1)	CL2008003097A1 (pt)
MX (1)	MX2010003346A (pt)
NZ (1)	NZ585348A (pt)
PE (1)	PE20091081A1 (pt)
RU (1)	RU2500681C2 (pt)
TW (1)	TWI445535B (pt)
UY (1)	UY31402A1 (pt)
WO (1)	WO2009050242A2 (pt)
ZA (1)	ZA201001621B (pt)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1847543A1 (de)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
CA2702500A1 (en) *	2007-10-18	2009-04-23	Boehringer Ingelheim International Gmbh	Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein
BRPI0817781A2 (pt)	2007-10-19	2019-09-24	Boehringer Ingelheim Int	piperazino-diidroteinopirimidinas substituídas com heterociclo
WO2009050236A1 (de)	2007-10-19	2009-04-23	Boehringer Ingelheim International Gmbh	Neue piperazino-dihydrothienopyrimidin-derivate
PT2215092E (pt) *	2007-10-19	2012-04-10	Boehringer Ingelheim Int	Piperidino-di-hidrotienopirimidinas substituídas
US8592400B2 (en)	2009-02-27	2013-11-26	Boehringer Ingelheim International Gmbh	Drug combinations containing PDE4 inhibitors and NSAIDs
JP2013529184A (ja)	2010-04-08	2013-07-18	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	Ｐｄｅ４阻害剤及びｅｐ４受容体アンタゴニストを含有する医薬の組み合わせ
US8609672B2 (en)	2010-08-27	2013-12-17	University Of The Pacific	Piperazinylpyrimidine analogues as protein kinase inhibitors
US9802954B2 (en)	2011-08-24	2017-10-31	Boehringer Ingelheim International Gmbh	Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
UA112897C2 (uk)	2012-05-09	2016-11-10	Байєр Фарма Акцієнгезелльшафт	Біциклічно заміщені урацили та їх застосування для лікування і/або профілактики захворювань
KR102214222B1 (ko) *	2013-07-10	2021-02-08	메이지 세이카 파루마 가부시키가이샤	신규 pde4 저해제
CN106279173A (zh) *	2015-05-29	2017-01-04	华东理工大学	蝶啶酮衍生物作为egfr抑制剂的应用
CN111108109A (zh)	2017-09-20	2020-05-05	利奥制药有限公司	取代的二氢噻吩并嘧啶及其作为磷酸二酯酶抑制剂的用途
CA3079299A1 (en)	2017-10-23	2019-05-02	Boehringer Ingelheim International Gmbh	New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (pf-ild)
ES2968822T3 (es)	2017-12-15	2024-05-14	Union Therapeutics As	Azetidina dihidrotienopirimidinas sustituidas y su uso como inhibidores de la fosfodiesterasa
WO2019115776A1 (en)	2017-12-15	2019-06-20	Leo Pharma A/S	Substituted azetidine dihydrothienopyridines and their use as phosphodiesterase inhibitors
JP7201688B2 (ja) *	2017-12-15	2023-01-10	ユニオン・セラピューティクス・アクティエセルスカブ	置換テトラヒドロピランジヒドロチエノピリミジンおよびホスホジエステラーゼ阻害剤としてのそれらの使用
KR102260995B1 (ko) *	2018-11-28	2021-06-04	국립암센터	Plk1의 활성 억제제를 유효성분으로 포함하는 암 예방 또는 치료용 약학적 조성물
CN113880859B (zh) *	2021-11-16	2022-06-21	江西科技师范大学	2-芳基-4-芳甲胺基嘧啶类化合物及其应用
WO2023104958A1 (en)	2021-12-09	2023-06-15	Boehringer Ingelheim International Gmbh	New oral pharmaceutical composition and dose regimen for the therapy of progressive fibrosing interstitial lung diseases
AU2022404695A1 (en)	2021-12-09	2024-05-02	Boehringer Ingelheim International Gmbh	New therapeutic combinations for the treatment of progressive fibrosing interstitial lung diseases
WO2023232135A1 (zh) *	2022-06-02	2023-12-07	西藏海思科制药有限公司	Pde4b抑制剂及其用途
TW202408518A (zh) *	2022-06-16	2024-03-01	大陸商武漢人福創新藥物研發中心有限公司	Pde4b抑制劑
WO2024032673A1 (zh) *	2022-08-09	2024-02-15	西藏海思科制药有限公司	Pde4b抑制剂及其用途
WO2024068386A1 (en)	2022-09-28	2024-04-04	Boehringer Ingelheim International Gmbh	Use of biomarkers in the treatment of fibrotic conditions with a pde4b-inhibitor

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE1470336A1 (de)	1962-07-04	1969-03-20	Thomae Gmbh Dr K	Neue Dihydrothieno-[3,4-d]-pyrimidine und Verfahren zu ihrer Herstellung
NL122810C (pt)	1963-06-17
DE1470356A1 (de)	1964-01-15	1970-04-30	Thomae Gmbh Dr K	Neue Thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
DE1940572A1 (de)	1969-08-08	1971-02-11	Thomae Gmbh Dr K	Neue 2-Aminoalkylamino-thieno[3,2-d]pyrimidine und Verfahren zu ihrer Herstellung
DE2032687A1 (en)	1970-07-02	1972-01-05	Dr. Karl Thomae Gmbh, 7950 Biberach	Cardiovascular 2-aminoalkylamino-thienopyrimidines - and 4-morpholino derivatives from 4-diethanolamino-compounds by intramolecular cyclisa
BE754606A (fr)	1969-08-08	1971-02-08	Thomae Gmbh Dr K	Nouvelles 2-aminoalcoylamino-thieno(3,2-d)pyrimidines et leurs procedesde fabrication
US3763156A (en)	1970-01-28	1973-10-02	Boehringer Sohn Ingelheim	2-heterocyclic amino-4-morpholinothieno(3,2-d)pyrimidines
RO58039A (pt) *	1970-01-28	1975-07-15
FR2082496A5 (pt)	1970-03-18	1971-12-10	Westinghouse Freins & Signaux
DE2121950A1 (en)	1971-05-04	1972-11-23	Dr. Karl Thomae Gmbh, 7950 Biberach	Thieno(3,2-d)pyrimidine derivs - with thrombocyte aggregation inhibiting activity
RO62428A (fr) *	1971-05-04	1978-01-15	Thomae Gmbh Dr K	Procede pour la preparation des thyeno-(3,2-d)-pyrimidines
DE2750288A1 (de)	1977-11-10	1979-05-17	Thomae Gmbh Dr K	Neue 9-(omega-heteroarylamino- alkylamino)-erythromycine, ihre salze, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
US4256737A (en)	1979-06-11	1981-03-17	Syntex (U.S.A.) Inc.	Long acting depot injectable formulations for LH-RH analogues
US5187168A (en)	1991-10-24	1993-02-16	American Home Products Corporation	Substituted quinazolines as angiotensin II antagonists
JPH07330777A (ja)	1994-06-08	1995-12-19	Taisho Pharmaceut Co Ltd	チエノ［３，２−ｄ］ピリミジン−４−オン誘導体
JPH09301958A (ja)	1996-05-09	1997-11-25	Nippon Shoji Kk	新規ピリミジン化合物及び抗ロタウイルス剤
DE19644228A1 (de) *	1996-10-24	1998-04-30	Merck Patent Gmbh	Thienopyrimidine
US6339089B2 (en)	1997-08-13	2002-01-15	Fujirebio Inc.	Pyrimidine nucleus-containing compound and a medicament containing the same for a blood oxygen partial pressure amelioration, and a method for preparing the same
DE10064994A1 (de)	2000-12-23	2002-07-04	Merck Patent Gmbh	Sulfamidothienopyrimidine
CN101100472A (zh)	2001-04-30	2008-01-09	美国拜尔公司	4-氨基-5,6-取代的噻吩并[2,3-d]嘧啶化合物及其应用
US6587548B2 (en)	2001-07-17	2003-07-01	Hewlett-Packard Development Co., L.P.	Method and system of using a single telephone number for multiple services
AU2002364211A1 (en)	2001-12-21	2003-07-15	Bayer Pharmaceuticals Corporation	Thienopyrimidine derivative compounds as inhibitors of prolylpeptidase, inducers of apoptosis and cancer treatment agents
JP4505228B2 (ja)	2002-01-10	2010-07-21	バイエル・シェーリング・ファルマ・アクチェンゲゼルシャフト	Ｒｈｏ−キナーゼ阻害剤
RS20050810A (en)	2003-04-29	2007-08-03	Pfizer Inc.,	5,7-diaminopyrazolo(4,3-d)pyrimidines useful in the treatment of hypertension
JP2005003345A (ja)	2003-05-21	2005-01-06	Showa Denko Kk	換気兼熱交換装置および空調システム
KR20150125731A (ko)	2003-10-02	2015-11-09	디에스엠 아이피 어셋츠 비.브이.	변형량의 염소 및 칼륨을 사용하는 미세조류 중에 고농도 디에치에이의 생산
MY141220A (en)	2003-11-17	2010-03-31	Astrazeneca Ab	Pyrazole derivatives as inhibitors of receptor tyrosine kinases
WO2005082865A1 (ja)	2004-02-27	2005-09-09	Astellas Pharma Inc.	縮合二環性ピリミジン誘導体
ES2328400T3 (es)	2005-04-21	2009-11-12	Boehringer Ingelheim International Gmbh	Dihidrotienopirimidinas para el tratamiento de enfermedades inflamatorias.
EP1847543A1 (de)	2006-04-19	2007-10-24	Boehringer Ingelheim Pharma GmbH & Co. KG	Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
DK2137196T3 (da)	2007-04-20	2011-01-10	Glaxo Group Ltd	Tricykliske nitrogenholdige forbindelser som antibakterielle midler
CA2702500A1 (en)	2007-10-18	2009-04-23	Boehringer Ingelheim International Gmbh	Preparation of dihydrothieno [3, 2-d] pyrimidines and intermediates used therein
AU2008312055A1 (en)	2007-10-19	2009-04-23	Astrazeneca Ab	Tetrazole derivatives as modulators of metabotropic glutamate receptors (mGluRs)
PT2215092E (pt)	2007-10-19	2012-04-10	Boehringer Ingelheim Int	Piperidino-di-hidrotienopirimidinas substituídas
WO2009050236A1 (de)	2007-10-19	2009-04-23	Boehringer Ingelheim International Gmbh	Neue piperazino-dihydrothienopyrimidin-derivate
EP2220061B1 (en)	2007-10-19	2016-02-17	Merck Sharp & Dohme Corp.	Spiro-condensed 1, 3, 4-thiadiazole derivatives for inhibiting ksp kinesin activity
BRPI0817781A2 (pt)	2007-10-19	2019-09-24	Boehringer Ingelheim Int	piperazino-diidroteinopirimidinas substituídas com heterociclo
CA2702447A1 (en)	2007-10-19	2009-04-30	Boehringer Ingelheim International Gmbh	New phenyl-substituted piperazino-dihydrothienopyrimidines
FR2922550B1 (fr)	2007-10-19	2009-11-27	Sanofi Aventis	Nouveaux derives de 6-aryl/heteroalkyloxy benzothiazole et benzimidazole, application comme medicaments, compositions pharmaceutiques et nouvelle utilisation notamment comme inhibiteurs de cmet
US8592400B2 (en)	2009-02-27	2013-11-26	Boehringer Ingelheim International Gmbh	Drug combinations containing PDE4 inhibitors and NSAIDs
WO2010097334A1 (de)	2009-02-27	2010-09-02	Boehringer Ingelheim International Gmbh	Arzneimittelkombinationen enthaltend pde4-inhibitoren und nsaids
US20130059866A1 (en)	2011-08-24	2013-03-07	Boehringer Ingelheim International Gmbh	Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma

2008
- 2008-10-16 BR BRPI0817781A patent/BRPI0817781A2/pt not_active IP Right Cessation
- 2008-10-16 JP JP2010529387A patent/JP5341899B2/ja active Active
- 2008-10-16 RU RU2010119645/04A patent/RU2500681C2/ru not_active IP Right Cessation
- 2008-10-16 EP EP08840075.9A patent/EP2205609B1/de active Active
- 2008-10-16 AU AU2008313742A patent/AU2008313742B2/en not_active Ceased
- 2008-10-16 NZ NZ585348A patent/NZ585348A/en not_active IP Right Cessation
- 2008-10-16 WO PCT/EP2008/063983 patent/WO2009050242A2/de active Application Filing
- 2008-10-16 MX MX2010003346A patent/MX2010003346A/es active IP Right Grant
- 2008-10-16 KR KR1020107008407A patent/KR20100075930A/ko not_active Application Discontinuation
- 2008-10-16 US US12/738,429 patent/US8637519B2/en active Active
- 2008-10-16 CN CN200880112298A patent/CN101827853A/zh active Pending
- 2008-10-16 CA CA2702524A patent/CA2702524A1/en not_active Abandoned
- 2008-10-17 TW TW097139972A patent/TWI445535B/zh not_active IP Right Cessation
- 2008-10-17 PE PE2008001794A patent/PE20091081A1/es not_active Application Discontinuation
- 2008-10-17 CL CL2008003097A patent/CL2008003097A1/es unknown
- 2008-10-17 AR ARP080104561A patent/AR069076A1/es unknown
- 2008-10-17 UY UY31402A patent/UY31402A1/es not_active Application Discontinuation
2010
- 2010-03-05 ZA ZA201001621A patent/ZA201001621B/xx unknown
2013
- 2013-12-19 US US14/134,367 patent/US9115142B2/en active Active

Also Published As

Publication number	Publication date
UY31402A1 (es)	2009-05-29
AR069076A1 (es)	2009-12-30
RU2010119645A (ru)	2012-01-27
US20140107103A1 (en)	2014-04-17
RU2500681C2 (ru)	2013-12-10
JP2011500639A (ja)	2011-01-06
CN101827853A (zh)	2010-09-08
KR20100075930A (ko)	2010-07-05
PE20091081A1 (es)	2009-08-24
NZ585348A (en)	2012-02-24
TWI445535B (zh)	2014-07-21
WO2009050242A3 (de)	2009-07-30
JP5341899B2 (ja)	2013-11-13
CA2702524A1 (en)	2009-04-23
AU2008313742A1 (en)	2009-04-23
EP2205609A2 (de)	2010-07-14
US8637519B2 (en)	2014-01-28
TW200918073A (en)	2009-05-01
EP2205609B1 (de)	2017-03-29
AU2008313742B2 (en)	2013-11-28
US9115142B2 (en)	2015-08-25
MX2010003346A (es)	2010-04-09
US20100305102A1 (en)	2010-12-02
WO2009050242A2 (de)	2009-04-23
ZA201001621B (en)	2010-10-27
CL2008003097A1 (es)	2010-01-22

Publication	Publication Date	Title
BRPI0817781A2 (pt)	2019-09-24	piperazino-diidroteinopirimidinas substituídas com heterociclo
DK2215092T3 (da)	2012-05-07	Substitueret piperidino-dihydrothienopyrimidin
DK2164844T3 (da)	2012-08-20	Pyrimidinyl-pyridazinonderivater
DK2209786T3 (da)	2013-06-03	Pyrimidinsubstituerede purinderivater
BRPI0818457A2 (pt)	2015-04-14	Derivados de oxadiazol
BRPI0813836A2 (pt)	2015-01-06	Derivados pirazólicos
DK2054394T3 (da)	2010-03-29	Piperazinforbindelser med herbicid virkning
BRPI0820112A2 (pt)	2015-05-05	Derivados de isoxazol-piridina
BRPI0809992A2 (pt)	2014-10-14	Derivados de pirrolopirimidina
BRPI0820113A2 (pt)	2015-05-05	Derivados de isoxazolo-piridazina
BRPI0813331A2 (pt)	2014-12-23	Derivados de piperidina/piperazina
BRPI0812923A2 (pt)	2014-12-09	Derivados de piperidina/piperazina
ATE518837T1 (de)	2011-08-15	Indazolamidderivate
BRPI0817935A2 (pt)	2015-04-07	Derivados de biarila
BRPI0812155A2 (pt)	2019-09-24	derivados de espiroindolinona
BRPI0906705A2 (pt)	2015-06-30	Composto heterocíclicos
BRPI0814236A2 (pt)	2015-01-06	Derivados de quinazolinamida
DE502008003324D1 (de)	2011-06-01	Heteroaryl-substituierte piperidine
BRPI0820649A2 (pt)	2015-06-16	Derivados de isoxazalo-pirazina
DK2152370T3 (da)	2011-08-15	Aryletherpyridazinonderivater
BRPI0821349A2 (pt)	2019-09-24	compostos antivirais heterocíclicos
BRPI0817579A2 (pt)	2015-04-07	Derivados de tiazol
DK2142533T3 (da)	2011-12-12	Imidazolidinonderivater
BRPI0813354A2 (pt)	2014-12-30	Derivado de morfolina
ATE519760T1 (de)	2011-08-15	Isoxazolimidazolderivate

Legal Events

Date	Code	Title	Description
2019-10-01	B08F	Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
2020-01-21	B08K	Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]	Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.